Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Professor Simon has been successful in her Wellcome Trust Investigator Award entitled: “Proteostasis and Autophagy in Immune Senescence.”

Katja Simon

Katja Simon, Professor of Immunology at the Kennedy Institute of Rheumatology has been awarded £1.8M over 5 years to explore the mechanics of autophagy and the role it plays in preventing ageing.

Healthcare challenges are intensifying as our population ages as age is the biggest single risk factor for many debilitating diseases, from infections to cancer. Immune ageing contributes by preventing useful immune responses as well as to other age-related diseases such as neurodegeneration, cardiovascular disease and cancer. But this process is little studied. Autophagy, a pathway activated when cells are stressed, clears away debris accumulated over time, recycling building blocks for re-use.

“Declining autophagy underpins ageing in many tissues, especially, as we have shown, in the immune system. We now want to identify what is degraded and what is generated by autophagy, to better understand how it prevents aging,” said Professor Simon. “I am delighted to receive this award as it will give my team and me the opportunity to study the underlying causes of aging both at a basic science level as well as trying to identify new drugs.

The award will enable Professor Simon to study how autophagy controls the amino acid pool and cellular energy levels and thereby protein synthesis. While protein synthesis levels decline with age, previous studies found that increasing the synthesis of autophagy proteins alone rejuvenates immune cells. By studying this pathway, they hope to identify new ways to prevent or even reverse the aging of immune cells.

Similar stories

New guidelines to improve reporting standards of studies that investigate causal mechanisms

Researchers at NDORMS have developed a new set of guidelines for reporting mediation analyses in health research.

New Associate Professors announced at NDORMS

The Medical Sciences Division has awarded the title of Associate Professor to five senior researchers at NDORMS.

COVID-19 vaccines shown to reduce infection by 90% in nursing homes

A new collaborative study between the Catalan Institute of Health, the Public Health Secreatariat of Catalonia, and the Centre for Statistics in Medicine, NDORMS, at the University of Oxford have confirmed that COVID-19 vaccines greatly reduce infections, hospitalisations and mortality for up to 6 months.

The Kennedy Institute completes its roof extension

Building work at the Kennedy Institute of Rheumatology has finished, providing a new third floor that houses additional meeting and collaboration space for data science and offices for the management of clinical trials.

Unlocking the secrets of the microbiome

Jethro Johnson, Deputy Director of the Oxford Centre for Microbiome Research explains how the centre is building a research community to understand the microbiome and harness its power to promote health and prevent disease.

Into the future: watching biology unfold

As part of the University of Oxford’s mission to provide its researchers with the newest state-of-the-art optical imaging equipment and as part of a strategic partnership with the Kennedy Institute of Rheumatology (KIR), the Institute of Developmental and Regenerative Medicine (IDRM), and Carl Zeiss AG (ZEISS), ZEISS has installed a ZEISS Lattice Lightsheet 7 microscope at the KIR.